Award of the Minister of Development and Technology “Polonica Progressio” for the innovative solution by Hemolens Diagnostics in the field of coronary artery disease diagnostics

Warsaw, 22 June 2023. – Wrocław-based Hemolens Diagnostics has been awarded this year’s “Polonica Progressio” award by the Minister of Development and Technology for its innovative solution in the field of non-invasive coronary artery disease diagnostics. 

This is the second edition of the award, and Minister Waldemar Buda’s initiative aims to honor businesses that have made a significant contribution to the development and promotion of the Polish economy. The award is intended to recognize work and engagement in building the brand of Poland in the world and enhancing the competitiveness of the Polish economy – the ability of companies to innovate, create added value, and care for local values while being open to change and working towards sustainable development. 

The “Polonica Progressio” competition features 6 categories: Leader of Sustainable Development, Leader of Foreign Expansion, Leader of Innovation, Leader of Technology Adoption, Leader of Management Capacity Development, and Leader of Partnership. In addition to the assessment of market position and the way in which business is developed, other important factors include the value and quality of investments made in Poland, the creation and implementation of innovations, combining a long history of business with the ability to adapt to a changing world and the implementation and promotion of measures for green transformation or building market competitiveness. 

In this year’s edition, Hemolens Diagnostics was recognized as a Technology Adoption Leader and awarded the prize at the Entrepreneur Gala, held in Warsaw at the Ministry of Development and Technology. A Technology Adoption Leader is a company that is successful in creating innovative technological solutions and using them to increase the efficiency and competitiveness of its business.  

Hemolens Diagnostics is a MedTech company specializing in the development and delivery of technology for personalized, non-invasive diagnostics. 

With the company’s developed technology, cardiologists will be able to obtain information about the condition of a patient’s coronary arteries in a non-invasive way. 

Hemolens Diagnostics is a good example of how Polish innovative solutions, created by young companies and dynamic teams, can improve quality of life and develop non-invasive diagnostics in Poland and around the world.